NL8701742A - Hydroximzuren van 7-oxabicycloheptaan gesubstitueerde ethers en thioethers. - Google Patents

Hydroximzuren van 7-oxabicycloheptaan gesubstitueerde ethers en thioethers. Download PDF

Info

Publication number
NL8701742A
NL8701742A NL8701742A NL8701742A NL8701742A NL 8701742 A NL8701742 A NL 8701742A NL 8701742 A NL8701742 A NL 8701742A NL 8701742 A NL8701742 A NL 8701742A NL 8701742 A NL8701742 A NL 8701742A
Authority
NL
Netherlands
Prior art keywords
chj
acid
oxabicyclo
solution
compound
Prior art date
Application number
NL8701742A
Other languages
English (en)
Dutch (nl)
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of NL8701742A publication Critical patent/NL8701742A/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NL8701742A 1986-07-23 1987-07-23 Hydroximzuren van 7-oxabicycloheptaan gesubstitueerde ethers en thioethers. NL8701742A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/888,671 US4673685A (en) 1986-07-23 1986-07-23 Hydroximic acids of 7-oxabicycloheptane substituted ethers and thioethers useful in the treatment of thrombotic disease
US88867186 1986-07-23

Publications (1)

Publication Number Publication Date
NL8701742A true NL8701742A (nl) 1988-02-16

Family

ID=25393633

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8701742A NL8701742A (nl) 1986-07-23 1987-07-23 Hydroximzuren van 7-oxabicycloheptaan gesubstitueerde ethers en thioethers.

Country Status (29)

Country Link
US (1) US4673685A (no)
JP (1) JP2557894B2 (no)
KR (1) KR950010596B1 (no)
AT (1) AT397094B (no)
AU (1) AU599384B2 (no)
BE (1) BE1000141A3 (no)
CA (1) CA1292003C (no)
CH (1) CH674010A5 (no)
DD (1) DD263990A5 (no)
DE (1) DE3724152A1 (no)
DK (1) DK383587A (no)
ES (1) ES2006784A6 (no)
FI (1) FI873207A (no)
FR (1) FR2601953B1 (no)
GB (1) GB2192882B (no)
GR (1) GR871147B (no)
HU (1) HU198495B (no)
IE (1) IE60487B1 (no)
IL (1) IL82919A0 (no)
IT (1) IT1222054B (no)
LU (1) LU86949A1 (no)
NL (1) NL8701742A (no)
NO (1) NO168359C (no)
NZ (1) NZ220677A (no)
PH (1) PH23711A (no)
PT (1) PT85381B (no)
SE (1) SE8702936L (no)
YU (1) YU46321B (no)
ZA (1) ZA874255B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8501035D0 (en) * 1985-01-16 1985-02-20 Senior J Prostaglandins
AU593316B2 (en) * 1986-02-14 1990-02-08 E.R. Squibb & Sons, Inc. Hydroxamic acids of 7-oxabicycloheptane substituted ethers
US4673685A (en) * 1986-07-23 1987-06-16 E. R. Squibb & Sons, Inc. Hydroximic acids of 7-oxabicycloheptane substituted ethers and thioethers useful in the treatment of thrombotic disease
US4925873A (en) * 1988-09-01 1990-05-15 E. R. Squibb & Sons, Inc. Method of treating skin injuries using thromboxane A2 receptor antagonists
US5093329A (en) * 1990-03-12 1992-03-03 Allergan, Inc. Intraocular pressure reducing prostaglandin-like 7-oxabicyclo derivatives

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4242273A (en) * 1977-09-27 1980-12-30 American Cyanamid Company 4-(Monoalkylamino)benzoic acid amides and imidates
US4254044A (en) * 1977-11-04 1981-03-03 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane- and 7-oxabicycloheptene compounds
US4220594A (en) * 1977-11-04 1980-09-02 E. R. Squibb & Sons, Inc. Hexa- and octahydro-4,7-epoxyisobenzofuran-1-ol and hexa- and octahydro-5,8-epoxy-1H-2-benzopyran-3-ol
US4187236A (en) * 1977-11-04 1980-02-05 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane compounds
US4143054A (en) * 1977-11-04 1979-03-06 E. R. Squibb & Sons, Inc. 7-oxabicycloheptane- and 7-oxabicycloheptene compounds
EP0013607B1 (en) * 1979-01-05 1983-03-23 National Research Development Corporation Substituted bicyclo (2,2,1)heptanes and bicyclo (2,2,1) hept-2-enes and their pharmaceutical compositions
US4440940A (en) * 1979-10-17 1984-04-03 American Cyanamid Company Anti-atherosclerotic agents
US4228180A (en) * 1979-11-01 1980-10-14 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane and 7-oxabicycloheptene prostaglandin analogs
ZA814307B (en) * 1980-07-01 1983-02-23 Nat Res Dev Prostaglandins
AU561739B2 (en) * 1981-12-23 1987-05-14 British Technology Group Limited Prostaglandins
US4466979A (en) * 1983-01-21 1984-08-21 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane substituted carbamate prostaglandin analogs useful in treating platelet aggregation and bronchoconstriction
US4474803A (en) * 1983-03-14 1984-10-02 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane substituted thio prostaglandin analogs useful in treating platelet aggregation and bronchoconstriction
CA1256887A (en) * 1983-03-14 1989-07-04 Steven E. Hall 7-oxabicycloheptane substituted prostaglandin analogs
US4513103A (en) * 1983-10-21 1985-04-23 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane ethers useful in the treatment of thrombolytic disease
US4526901A (en) * 1984-01-26 1985-07-02 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane substituted oxamide prostaglandin analogs and their use in treating thrombolytic disease
US4536513A (en) * 1984-03-14 1985-08-20 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane substituted prostaglandin interphenylene analogs useful in the treatment of thrombolytic disease
US4661506A (en) * 1984-11-30 1987-04-28 E. R. Squibb & Sons, Inc. 7-oxabicycloheptane substituted ox prostaglandin analogs
US4654367A (en) * 1986-02-14 1987-03-31 E. R. Squibb & Sons, Inc. Hydroxamic acids of 7-oxabicycloheptane substituted ethers useful as anti-allergy and anti-inflammation agents
US4652578A (en) * 1986-02-24 1987-03-24 E. R. Squibb & Sons, Inc. 7-oxabicycloheptane substituted amide prostaglandin analogs
US4673685A (en) * 1986-07-23 1987-06-16 E. R. Squibb & Sons, Inc. Hydroximic acids of 7-oxabicycloheptane substituted ethers and thioethers useful in the treatment of thrombotic disease

Also Published As

Publication number Publication date
YU46321B (sh) 1993-05-28
AU7444887A (en) 1988-01-28
ZA874255B (en) 1988-02-24
GR871147B (en) 1987-12-04
JPS6335576A (ja) 1988-02-16
IT8721328A0 (it) 1987-07-16
FR2601953A1 (fr) 1988-01-29
NO168359C (no) 1992-02-12
SE8702936L (sv) 1988-04-07
IE871675L (en) 1988-01-23
SE8702936D0 (sv) 1987-07-22
DD263990A5 (de) 1989-01-18
US4673685A (en) 1987-06-16
GB2192882A (en) 1988-01-27
FI873207A (fi) 1988-01-24
AU599384B2 (en) 1990-07-19
HU198495B (en) 1989-10-30
NZ220677A (en) 1989-12-21
CA1292003C (en) 1991-11-12
PH23711A (en) 1989-09-27
NO873069L (no) 1988-01-25
ATA174887A (de) 1993-06-15
PT85381B (pt) 1990-04-30
CH674010A5 (no) 1990-04-30
BE1000141A3 (fr) 1988-05-03
NO873069D0 (no) 1987-07-22
KR950010596B1 (ko) 1995-09-20
FR2601953B1 (fr) 1990-11-16
DK383587A (da) 1988-01-24
GB8714621D0 (en) 1987-07-29
JP2557894B2 (ja) 1996-11-27
HUT47115A (en) 1989-01-30
YU138187A (en) 1988-12-31
GB2192882B (en) 1990-05-09
LU86949A1 (fr) 1988-02-02
DE3724152A1 (de) 1988-02-04
FI873207A0 (fi) 1987-07-21
PT85381A (en) 1987-08-01
NO168359B (no) 1991-11-04
IL82919A0 (en) 1987-12-20
DK383587D0 (da) 1987-07-22
ES2006784A6 (es) 1989-05-16
IE60487B1 (en) 1994-07-27
AT397094B (de) 1994-01-25
KR880001660A (ko) 1988-04-25
IT1222054B (it) 1990-08-31

Similar Documents

Publication Publication Date Title
US7407975B2 (en) Epothilone derivatives, method for producing same and their pharmaceutical use
US4536513A (en) 7-Oxabicycloheptane substituted prostaglandin interphenylene analogs useful in the treatment of thrombolytic disease
US4647585A (en) Bicycloheptane substituted ethers
US4555523A (en) 7-Oxabicycloheptane substituted thio prostaglandin analogs and their use in the treatment of thrombolytic disease
DE3625870A1 (de) 7-oxabicycloheptansubstituierte amid-thioamid-prostaglandin-analoge
NL8701742A (nl) Hydroximzuren van 7-oxabicycloheptaan gesubstitueerde ethers en thioethers.
US4524151A (en) 7-Oxabicycloheptane thio ethers useful as cardiovascular agents
EP0447188A2 (en) 7-Oxabicycloheptane imidazole prostaglandin analogs useful in the treatment of thrombotic and vasospastic diseases
US4536514A (en) 7-Oxabicycloheptane substituted prostaglandin analogs useful in the treatment of thrombolytic disease
US4608386A (en) 7-oxabicycloheptane ethers useful in the treatment of thrombotic diseases
US4661506A (en) 7-oxabicycloheptane substituted ox prostaglandin analogs
US4542156A (en) 7-Oxabicycloheptane substituted prostaglandin alcohols and their use in the treatment of thrombolytic disease
US4591603A (en) 7-oxabicycloheptane substituted prostaglandin analogs useful in the treatment of thrombotic disease
US4550120A (en) 7-Oxabicycloheptane substituted ethers and their use in treating thrombolytic disease
US4526900A (en) 7-Oxabicycloheptane substituted oxa prostaglandin analogs and their use in the treatment of thrombolytic disease
US4652576A (en) 7-oxabicycloheptane substituted amide-carbamate prostaglandin analogs
EP0159528A1 (en) Tetrahydrofuranyl substituted prostaglandin analogs
US4611007A (en) 7-oxabicycloheptane substituted prostaglandin analogs useful in the treatment of thrombotic disease
DE3715208A1 (de) 7-oxabicycloheptan-substituierte amido-carbamoyl-prostaglandin-analoge
US4654364A (en) Hydroxamic acids of 7-oxabicycloheptane substituted ethers
US4654367A (en) Hydroxamic acids of 7-oxabicycloheptane substituted ethers useful as anti-allergy and anti-inflammation agents
US4654366A (en) Hydroxamic acids of 7-oxabicyclo[2.2.1]heptane substituted ethers useful as anti-thrombotic agents
JP2523121B2 (ja) ７−オキサビシクロヘプタン置換エ−テル類のヒドロキサム酸類
CA1294972C (en) 7-oxabicyclo(2.2.1)heptane-based derivatives

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
BV The patent application has lapsed